Gammagard liquid 10% vial 100ML

Ended Awarded

Contract number
SPE2DX25F6AFP
Awardee
Awarding agency
Obligated
$21,372

Award facts

Contract value 100% obligated
$21,372.24 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $21,372.24 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Gammagard Liquid 10% in 100ml vials. The contract, which carries a firm fixed-price structure with an ultimate completion date of September 30, 2025, was issued without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the delivery at its facility location. The company leverages its position as a vendor under the DLA's larger SPE2DB Indefinite Delivery Contract, valued at $499,999,999 through November 2026, which enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting military healthcare facilities worldwide.

DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract performance delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. The company's pharmaceutical portfolio encompasses a broad range of products including specialty medications, injections, and immunoglobulin products such as the Gammagard Liquid specified in this delivery order. As a woman-owned small business registered in SAM.gov since 2001, DMS Pharmaceutical Group competes effectively in federal procurement without requiring set-aside designations, demonstrating the company's competitive strength in the federal pharmaceutical distribution market.

Quick answers

Who was awarded contract SPE2DX25F6AFP?

SPE2DX25F6AFP was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 9, 2025.

How much is contract SPE2DX25F6AFP worth?

The government has obligated $21,372 on SPE2DX25F6AFP.

Is contract SPE2DX25F6AFP an order under another contract?

Yes. SPE2DX25F6AFP is a delivery order under SPE2DX15D9114, an indefinite delivery contract.

Was contract SPE2DX25F6AFP competed?

The extent of competition for SPE2DX25F6AFP was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award